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Background: Specific mutations in the chaperone protein CSP cause adult-onset neuronal ceroid lipofuscinosis.
Results: These mutants form SDS-resistant aggregates in a palmitoylation-dependent manner in cell lines and brain samples
from mutation carriers.
Conclusion: Palmitoylation induces disease-causing CSPmutants to form SDS-resistant aggregates.
Significance: Formation of SDS-resistant CSP aggregates may underlie development of adult-onset neuronal ceroid
lipofuscinosis.
Recently, mutations in the DNAJC5 gene encoding cysteine-
string protein  (CSP) were identified to cause the neurode-
generative disorder adult-onset neuronal ceroid lipofuscinosis.
The disease-causing mutations (L115R or L116) occur within
the cysteine-string domain, a region of the protein that is post-
translationally modified by extensive palmitoylation. Here we
demonstrate that L115R andL116mutant proteins aremistar-
geted in neuroendocrine cells and form SDS-resistant aggre-
gates, concordant with the properties of other mutant proteins
linked to neurodegenerative disorders. The mutant aggregates
are membrane-associated and incorporate palmitate. Indeed,
co-expression of palmitoyltransferase enzymes promoted the
aggregation of the CSP mutants, and chemical depalmitoyla-
tion solubilized the aggregates, demonstrating that aggregation
is induced andmaintained by palmitoylation. In agreementwith
these observations, SDS-resistant CSP aggregates were pres-
ent in brain samples from patients carrying the L115Rmutation
and were depleted by chemical depalmitoylation. In summary,
this study identifies a novel interplay between geneticmutations
and palmitoylation in driving aggregation of CSPmutant pro-
teins.We propose that this palmitoylation-induced aggregation
of mutant CSP proteins may underlie the development of
adult-onset neuronal ceroid lipofuscinosis in affected families.
Neuronal ceroid lipofuscinoses (NCLs)2 are a group of neu-
rodegenerative disorders, with a hallmark accumulation of
autofluorescent lipid- and protein-rich ceroid (lipofuscin) in
neurons and other cell types (1). NCLs are classified as early
infantile, late infantile, juvenile, and adult, depending upon the
age of symptomatic onset. The genes affected in different NCLs
have been characterized and encode predominantly lysosomal
proteins (1); for example,mutations in theCLN1 gene encoding
the lysosomal enzyme protein palmitoyl thioesterase 1 can
cause infantile NCL (2); protein palmitoyl thioesterase 1 func-
tions in the removal of fatty acid groups from palmitoylated
proteins during their lysosomal degradation (3).
Symptoms of adult-onset NCL (ANCL) usually precipitate
before the age of 40 and lead to a significant decrease in life
expectancy. Unlike other NCLs, which tend to be autosomal
recessive, ANCL can be either autosomal recessive or auto-
somal dominant (4). Three studies published in 2011–2012
identified mutations in the DNAJC5 gene encoding cysteine-
string protein  (CSP) as the cause of autosomal dominant
ANCL in several unrelated families (5–7).
CSP is a ubiquitously expressed DnaJ chaperone protein
that regulates proteins involved in secretory vesicle dynamics
(8–10). Knock-out of CSP in mice leads to fulminant neuro-
degeneration (11), likely by destabilizing key synaptic proteins
such as SNAP25 (12, 13) and dynamin (14, 15). The mutations
in CSP that cause ANCL occur within the highly conserved
cysteine-string region, a heavily palmitoylated domain involved
in membrane binding and intracellular targeting. The specific
mutations identified were a substitution of leucine 115 by argi-
nine (L115R) or a deletion of leucine 116 (L116) (5–7).
The cysteine-string domain of CSP plays a dual role in pro-
moting stable membrane attachment (16, 17). First, the overall
hydrophobicity of this region may allow transient membrane
interaction of the nonpalmitoylated protein, allowing it to con-
nect with membrane-bound Asp-His-His-Cys (DHHC) palmi-
toyltransferases. Subsequent palmitoylation of the cysteine-
string domain by specific DHHC proteins promotes stable
membrane attachment, facilitating trafficking to secretory ves-
icles and the plasmamembrane. In addition, the cysteine-string
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domain may also be involved in homodimerization and multi-
merization of CSP (18).
The role of the cysteine-string domain inmembrane binding,
palmitoylation, and multimerization of CSP suggests that
L116 and L115R mutations may perturb any one of these
parameters. However, to date, analysis of the effects of the
mutations have mainly used in silico modeling. A Kyte-
Doolittle algorithm revealed a decrease in hydrophobicity of
the cysteine-string domain for the L115Rmutant and a smaller
nonsignificant decrease for theL116mutant (6, 7). Additional
in silico analysis revealed that both disease-causing mutations
reduce the propensity of the cysteine-string domain to move
from water to a phosphocholine bilayer interface, reducing the
membrane affinity of CSP (7). CSS-Palm software, which is
used to identify putative palmitoylation sites, suggested a min-
imal effect of the mutations on palmitoylation per se, possibly
with the modification of one cysteine compromised as a conse-
quence of the L115R mutation (7). In silico analysis did not
reveal a consistent effect of the mutations on protein aggrega-
tion; however, this analysis highlighted the high intrinsic tend-
ency to form antiparallel -sheets species of CSP and the
mutants (7). In addition to these in silico analyses, some exper-
imental data were presented by Nosková et al. (6), which sug-
gested that the mutants were mislocalized and exhibited a very
modest decrease in palmitoylation.
Although potentially powerful, caution must be exercised
when interpreting results of these in silico analyses for the fol-
lowing reasons: (i) the structure of the cysteine-string domain is
not known, significantly weakening the reliability of nonexperi-
mental measurements; (ii) aggregation propensity is not simply
related to the amino acid sequence of CSP but may also be
dependent on the palmitoylation status of the protein and rel-
ative cytosol-membrane distribution; (iii) palmitoylation of
CSP is tightly linked with the intrinsic membrane affinity of
the cysteine-string domain; (iv) palmitoylation prediction pro-
grams do not consider the properties of the individual DHHC
proteins that modify CSP. In short, the in silico analyses per-
formed to date may not adequately (if at all) define how the
L115R and L116 mutations affect the cellular properties of
CSP and cause autosomal dominant ANCL.
EXPERIMENTAL PROCEDURES
Mammalian Plasmids and Mutagenesis—The human CSP
coding sequence lacking the initiating methionine and flanked
by HindIII and BamHI restriction sites was synthesized by
GeneArt (Invitrogen). Human CSP contains an intrinsic Hin-
dIII restriction site, and this was removed by introducing a
silent mutation (AAG3AAA). This CSP sequence was
inserted in-frame into the pEGFP-C2 vector. To generate
myc-tagged constructs, bovine CSP was excised from a
myc-pcDNA3.1 construct (9) using BamHI and EcoRI enzymes
and replaced with the human CSP coding sequences. HA-
tagged DHHC constructs were a kind gift from Masaki Fukata
(19). The sequences of all plasmid constructs were verified by
DNA sequencing (DNA Sequencing Service, Dundee, UK).
Antibodies—Rabbit polyclonal antibody recognizing CSP
was purchased from Stressgen (Victoria, Canada). HSC70 anti-
bodywas fromNewEnglandBiolabs (Herts, UK). GFP antibody
(JL8) was fromClontech. RabbitMyc andmouse actin antibod-
ies were from Abcam. Rat HA antibody (used for immunoblot-
ting) was purchased from Roche Applied Science, and mouse
HA antibody (used for immunofluorescence) was from Cova-
nce (Paris, France).
Cell Culture and Transfection—PC12 cells were cultured in
RPMI 1640 medium with 10% horse serum and 5% fetal bovine
serum. HEK293T cells were cultured in DMEM with 10% fetal
bovine serum. All cells were grown in a humidified atmosphere
at 37 °C and 5% (HEK293T) or 7.5% (PC12) CO2.
Lipofectamine 2000 (Invitrogen) was used for all transfec-
tions at 2 l/g DNA. For confocal microscopy, PC12 cells
were plated on poly-D-lysine glass coverslips and transfected
with 0.5 g of EGFP-CSP plasmids and analyzed40 h later.
For biochemical analysis, PC12 cells growing on poly-D-lysine-
coated 24-well plates were transfected with 1 g of plasmid
DNA and analyzed 40 h after transfection. HEK293T cells
were transfected with 0.8 g of EGFP-CSP and 1.6 g of the
indicated HA-tagged DHHC constructs and analyzed 20 h
later.
Cell Fixation, Labeling, and Confocal Microscopy—Trans-
fected cells were fixed in 4% formaldehyde. For antibody stain-
ing, the cells were then permeabilized in 0.25%TritonX-100 (in
PBS with 0.3% BSA) and incubated successively with primary
antibody (1:50) and Alexa Fluor 546-conjugated secondary
antibody (1:400; Invitrogen). The cells were then washed in
PBS, air-dried, and mounted on glass slides in Mowiol. A Leica
SP5 laser scanning confocal microscope was used to view cel-
lular fluorescence. Image stacks of PC12 cells were acquired at
Nyquist sampling rates and deconvolved using Huygens soft-
ware (Scientific Volume Imaging).
SDS-PAGE—Samples were diluted in SDS-dissociation
buffer (final concentration 2% SDS, 25 mM DTT, 10% glycerol,
0.01% bromphenol blue, 50 mM Tris, pH 6.8) heated to 100 °C
for 5 min and loaded onto 12% polyacrylamide gels.
Cell Fractionation—Transfected PC12 or HEK293T cells on
24-well plates were resuspended in a buffer containing 5 mM
Hepes, and 1 mM EDTA, pH 7.4, supplemented with a protease
inhibitor mixture (Sigma) and with or without 1% Triton
X-100. The cells were frozen at 80 °C, thawed, and centri-
fuged at 16,000  g for 30 min at 4 °C. Recovered supernatant
and pellet fractions were made up to an equal volume in SDS-
dissociation buffer and resolved by SDS-PAGE.
Preparation of Human Brain Lysates—Lysates from human
postmortem brain samples were prepared by homogenization
(Dounce homogenizer) in ice-cold buffer composed of 20 mM
Hepes, 250 mM sucrose, 1 mM MgCl2, 2 mM EDTA, 1% Triton
X-100, and protease inhibitor mixture (Sigma), pH 7.4. Insolu-
ble material was removed by centrifugation 4000  g for 10
min. Cortical brain tissue from histologically characterized
normal brain tissues authorized for ethically approved scien-
tific research (Lothian Research Ethical Committee; reference
2003/8/37) were gratefully provided by Robert Walker at the
Medical Research Council Sudden Death Brain and Tissue
Bank, University of Edinburgh (20). Cortical tissue fromANCL
patients carrying the L115R mutation was obtained from
Washington University School of Medicine in St. Louis ADRC.
All tissue used was from anonymized patients, and ethical
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approval for the work was granted by the University of Strath-
clyde (reference UEC1112/46).
Chemical Depalmitoylation of CSP—Human brain lysates
(100 g of protein) were incubated overnight at room temper-
ature in 0.5 M hydroxylamine, pH 7, or 0.5 M Tris, pH 7, supple-
mentedwith a protease inhibitormixture (Sigma). EGFP-CSP
exhibited proteolysis following extended incubation times in
hydroxylamine, and therefore cells expressing EGFP-tagged
constructs were treated with 0.5 M Tris-HA for 2 h. Following
treatment, the cell samples were diluted in SDS-dissociation
buffer and resolved by SDS-PAGE.
[3H]Palmitic Acid Labeling Experiments—Transfected
HEK293T cells were washed in DMEM supplementedwith 10
mg/ml defatted BSA and then incubated in the same medium
containing 0.5mCi/ml [3H]palmitic acid (PerkinElmer Life Sci-
ences) for 3 h. Cells were then lysed in SDS-dissociation buffer,
resolved by SDS-PAGE, and transferred to nitrocellulose.
Duplicate nitrocellulose membranes with either processed for
immunoblotting or used for detection of 3H signal with the aid
of a Kodak Biomax Transcreen LE intensifier (PerkinElmer Life
Sciences).
Split Ubiquitin System—Gateway-compatible mouse DHHC17/
DHHC3 and human CSP cDNAs were produced by PCR and
inserted using Gateway technology into pDONR207 and then
into pMetYC-Dest (bait plasmid) and pNX32-Dest (prey plas-
mid) respectively. After transformation of THY.AP4 and
THY.AP5 yeast strains with bait and prey plasmids, respec-
tively, the two strains were mated. Growth of diploid cells was
monitored after dropping of 5 l of each yeast suspension (at
A600 1 or 0.1) on synthetic defined medium plates (1.7 g/liter
yeast nitrogen base without ammonium sulfate, 5 g/liter
ammonium sulfate, 20 g/liter glucose, 1.5 g/liter CSM-Ade,-
His,-Trp,-Leu,-Ura,-Met drop-outmix, and 20 g/liter agar) and
subsequent growth for 4 days at 30 °C (for interactions with
DHHC17) or 7 days (for interactions with DHHC3). As a load-
ing control and to verify matings, the same amounts were
dropped onto plates with synthetic defined medium supple-
mented with adenine and histidine, and growth was monitored
after 3 days at room temperature. Yeast transformations, mat-
ing, and sample preparation for Western blotting were per-
formed as described in Ref. 21.
Quantification and Statistical Analyses—Densitometric
quantification of immunoblots was performed using ImageJ
software (National Institutes ofHealth). Statistical analyses was
by a one-way ANOVA using the Analyze-It plugin for
Microsoft Excel; a p value of0.05 was taken to represent sta-
tistical significance. For quantification of aggregation, the den-
sity of aggregates was expressed as a ratio to monomeric forms
of the protein (corresponding to the sum of the nonpalmitoy-
lated and palmitoylated bands).
RESULTS
Mutant CSP Proteins AreMistargeted and Form SDS-resist-
ant Aggregates—A schematic diagram of the domain structure
of CSP is shown in Fig. 1A, highlighting the position of the
residues (leucine 115 and leucine 116) that are mutated in
ANCL. As a first step toward the identification of acquired bio-
chemical properties of CSP proteins containing the L116
and L115R mutations, EGFP-tagged forms of these proteins
were expressed in neuroendocrine PC12 cells and analyzed by
confocal microscopy and SDS-PAGE/immunoblotting. Wild-
type EGFP-CSP associates with the plasma membrane and
vesicles in PC12 cells (16) (Fig. 1B, left). In contrast, both the
L116 and L115R mutants displayed a more dispersed and
punctate localization and a reduced plasmamembrane staining
(Fig. 1B,middle and right).
As intracellular targeting of CSP is dependent upon multi-
ple palmitoylation of the cysteine-string domain (16), we next
examined whether this modification was perturbed for the
mutant proteins. The palmitoylation status of CSP can be
readily assessed by its migration profile on SDS gels, as the fully
palmitoylated form of the protein migrates approximately 7
kDa heavier than the nonpalmitoylated protein (16, 17, 22). The
migration of palmitoylated (p) and nonpalmitoylated (np)
bands of wild-type EGFP-CSP expressed in PC12 cells is
shown in Fig. 1C (note that we confirm that the upper band is
palmitoylated in subsequent figures). Interestingly, for the
L116 and L115R mutants there was a clear absence of palmi-
toylated monomeric forms of the proteins (Fig. 1C), and the
mutations induced the formation of SDS-resistant aggregates
(Fig. 1C, quantified in the right panel). These aggregates
migrated predominantly as two distinct higher molecular mass
bands, with the upper band remaining in the stacking gel (Fig.
1C). To confirm that aggregation was not dependent on the
EGFP tag, myc-tagged forms of the CSP proteins were also
examined, confirming the near absence of palmitoylatedmono-
meric forms of the mutant proteins and formation of high
molecular mass aggregates (Fig. 1D).
In contrast to the L115R mutant, a CSP(L115A) mutant
exhibited the same migration profile on SDS gels as wild-type
CSP (Fig. 1E), demonstrating that the defects in the L115R and
L116mutants likely arise due to a loss of overall hydrophobic-
ity rather than a specific requirement for an intact dileucine
motif.
Finally, we examined whether the mutant aggregates were
cytosolic or membrane-associated. For this, transfected PC12
cells were disrupted by freeze/thawing and fractionated into
cytosol and membrane fractions by centrifugation. Immu-
noblotting for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and syntaxin 1A confirmed the successful separation
of cytosolic and membrane proteins in supernatant and pellet
fractions, respectively (Fig. 1F). The L116 and L115R aggre-
gates were enriched in the membrane fraction (Fig. 1F). To
confirm that the aggregates are trulymembrane-associated and
not pelleting due to their large size, the fractionation protocol
was also performed in the presence of Triton X-100 to solubi-
lize bulk cellular membranes. Under these conditions, the
majority of themutant aggregates did not pellet, supporting the
idea that they are predominantly membrane-associated in
PC12 cells.
CSP Mutants Display Efficient Interaction with DHHC
Palmitoyltransferases—The cysteine-string domain of CSP,
where the disease-causingmutations occur, has 14 cysteine res-
idues in a span of 24 amino acids. One possibility to explain the
observed aggregation of CSP mutants is that the mutations
prevent palmitoylation of the protein, and aggregation is caused
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by the presence ofmany unmodified cysteines. To examine this,
we first tested whether the mutations blocked interaction with
DHHC palmitoyltransferases. In mammalian cells at least 24
DHHC proteins are expressed (23), and CSP can be palmitoy-
lated by DHHC3, DHHC7, DHHC15, or DHHC17 (17). Here,
we focused on the interaction of CSP with DHHC17 and
DHHC3; knock-out of DHHC17 led to a complete loss of CSP
palmitoylation in Drosophila (24). The split-ubiquitin system
(SUS) was used to study the interaction betweenCSP proteins
and DHHC17/3 (21). This assay depends on the release of
LexA-VP16 transactivator following reassembly of N- and
C-terminal halves of ubiquitin, which are fused to the interact-
ing proteins of interest. Reassembled ubiquitin is cleaved by
ubiquitin-specific proteases, leading to the release of LexA-
VP16. Nuclear translocation of LexA-VP16 allows yeast cells to
grow on media lacking adenine and histidine. No major differ-
ence was detected in the ability of wild-type CSP or theL116
and L115R mutants to interact with DHHC17 in the SUS (Fig.
FIGURE 1. Localization and biochemical properties of L115R andL116mutants in PC12 cells. A, schematic diagram of CSP showing relative positions
of the DnaJ and cysteine-string domains and highlighting the positions of amino acids lysine 115 and 116. B, PC12 cells transfected with EGFP-tagged CSP
constructs and examined by confocal microscopy. Representative maximum intensity projections of deconvolved image stacks are presented for the local-
ization of each construct. Scale bars represent 5 m, and the color coding of fluorescence intensity profile is indicated. C, left panel, migration profile of
wild-type andmutant forms of EGFP-taggedCSPproteins on SDS gels revealed by immunoblottingwith anti-GFP. Right panel, mean values S.E. (error bars)
for the ratio of aggregated to monomeric forms of the proteins (n  4). The data were analyzed using a one-way ANOVA, asterisks denote a significant
difference fromwild-type CSP (p 0.05). D, migration profile of wild-type andmutant forms of myc-tagged CSP on SDS gels revealed by immunoblotting
with anti-myc antibody. E, migration profile of wild-type and mutant forms of the indicated EGFP-tagged CSP constructs on SDS gels revealed by immuno-
blotting with anti-GFP antibody. F, PC12 cells expressing the indicated CSP proteins separated into supernatant (S) and pellet (P) fractions, containing
cytosolic andmembrane proteins, respectively. The fractionation was performed in the presence and absence of 1% Triton X-100 as indicated. Equal volumes
of the recovered samples were resolved by SDS-PAGE, transferred to nitrocellulose, and probed with antibodies against GFP, syntaxin 1A, and GAPDH. C–F, a
denotes aggregates, p shows position of palmitoylated monomeric CSP, and np highlights the nonpalmitoylated monomers. Positions of molecular mass
markers are shown on the left.
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2). In contrast, a CSP mutant truncated before the cysteine-
string domain (amino acids 1–112) displayed a greatly reduced
interactionwithDHHC17under stringent conditions (with 200
M methionine), confirming the ability of the system to report
reliably on protein-protein interactions. The interaction of
CSPwithDHHC3 in the SUSwas weaker thanwithDHHC17.
Nevertheless, longer growth times (7 days compared with 4
days for DHHC17) allowed a robust measurement of CSP-
DHHC3 interaction. As with DHHC17, no difference was
detected in the ability of wild-type and mutant CSP proteins
to interact with DHHC3; no interaction was detected between
DHHC3 and CSP(1–112) under any conditions.
Co-expression of Active DHHC Proteins Promotes Aggrega-
tion of CSPMutants—The results of the SUS (Fig. 2) did not
uncover a difference in the interactions of the mutant CSP
proteins with DHHC3 and DHHC17. To investigate palmitoy-
lation of the CSPmutants further, we co-expressed these pro-
teins with DHHC3 in HEK293T cells. In contrast with PC12
cells (Fig. 1), overexpressed wild-type CSP is only weakly
palmitoylated in HEK293T cells, but co-expression of specific
DHHC proteins (including DHHC3) leads to a large increase in
palmitoylation of CSP (17). As described previously (17), co-
expression of DHHC3 increased palmitoylation of wild-type
CSP, as detected by a shift in migration on SDS gels (Fig. 3A).
Interestingly, the CSPmutants exhibited a low level of aggre-
gation in HEK293T cells when expressed individually, and this
aggregation was markedly increased by co-expression of
DHHC3 (Fig. 3A). Note that DHHC3 did not co-aggregate with
the mutant CSP proteins (Fig. 3A, lower). In addition to pro-
moting aggregation of the CSP mutants, co-expression with
DHHC3 also led to redistribution of theL116 and L115R pro-
teins from the cytosol onto Golgi membranes (Fig. 3, B and C).
Note that CSP is not efficiently trafficked onto post-Golgi
membranes in this co-expression assay in HEK293T cells,
explaining the difference in localization with PC12 cells (Fig.
1B). We also confirmed that the mutant aggregates were mem-
brane-associated following DHHC3 co-expression by cellular
fractionation (Fig. 3D).
Before proceeding with further analyses of CSP palmitoy-
lation and aggregation, we examined whether the conditions
used in sample preparation for SDS-PAGE (including heating
samples to 100 °C in 25 mM DTT) might be affecting palmitoy-
lation or aggregation of the mutant CSP proteins. For this, we
compared the migration of wild-type and mutant CSP pro-
teins on SDS gels following preparation in SDS sample buffer
containing 1, 5, and 25 mM DTT and with or without sample
boiling. Fig. 3E shows that there was very little difference in the
migration of mutant CSP proteins under the different condi-
tions tested except for the appearance of a small amount of a
band corresponding in size to dimeric CSP (band slightly
below the 175-kDa molecular mass marker) in nonboiled sam-
ples, the presence of which was more pronounced with the
wild-type protein.
Having confirmed that palmitoylation and aggregation of the
mutant CSP proteins was not being significantly affected by
the sample preparation conditions, we proceeded to examine
the effects of DHHCproteins onmutant CSP aggregation fur-
ther. We examined whether the increase in aggregation of
mutant CSP proteins occurred with other DHHC proteins
and whether it required the palmitoyltransferase activity of
these proteins (palmitoyltransferase activity is abolished by
mutation of theDHHCmotif to DHHS). Indeed, aggregation of
the CSP mutants was promoted by co-expression with
DHHC3, DHHC7, and DHHC17 but not by the inactive forms
of these palmitoyltransferases (Fig. 3F). These findings clearly
FIGURE2. InteractionofCSPmutantswithDHHCpalmitoyltransferases.
Yeast diploids were created by mating cells expressing a C-terminal half of
ubiquitin and PLV (protein A-LexA-VP16) tag fused to the C termini of
DHHC17 (top panel) or DHHC3 (middle panel) with cells expressing the wild-
type form of the N-terminal half of ubiquitin (NubWT; positive control), a
mutant form of the N terminus that does not spontaneously reassemblewith
the C terminus of ubiquitin (NubG; negative control), or NubG fused to the N
terminus ofwild-type CSP, or L115R,L116, and CSP(1–112)mutants. Dip-
loids were spotted ontomedium containing adenine (Ade) and histidine (His)
to verify equal plating density and plated on medium lacking Ade/His to
determine protein-protein interaction; methionine was added to confirm
interaction at lower expression levels. 0.1 and 1 refer to the A600 of liquid
culture dropped onto the plates. Yeast diploids containing DHHC17 and all
CSP constructs displayed growth on plates without Ade/His (second panel);
however, under more stringent conditions in the presence of methionine
(expression of the bait is regulated by a methionine-repressible promoter)
(third and fourth panels) growthof cells expressing the1–112mutantwas lost,
whereas wild-type, L115R, and L116 constructs all supported growth. Simi-
lar results were obtained with DHHC3, although in this case no growth was
detected in diploids containing DHHC3 and the 1–112 mutant on any plates
lackingAde/His. Images forgrowthonplates lackingAde/Hiswere takenafter
4 days for DHHC17 and 7 days for DHHC3. The bottom panel shows an immu-
noblot probed with anti-HA, confirming expression of all of the CSP con-
structs; positions of molecular mass markers are shown on the left.
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link palmitoylation by DHHC proteins with the induction of
aggregation of CSP proteins carrying the L115R or L116
mutations.
CSP Mutant Aggregates Are Disrupted by Chemical
Depalmitoylation—Only active forms ofDHHC3/7/17 are able
to promote aggregation of the CSP L116 and L115R
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mutants, implying that palmitoylation drives aggregate forma-
tion. To assess the palmitoylation status of the L116 and
L115R aggregates, HEK293T cells expressing the mutants
with or without DHHC3 co-expression were labeled with
[3H]palmitic acid. Aggregated forms of the CSP mutants
clearly incorporated radiolabel, and this was enhanced by
DHHC3 co-expression (Fig. 4A, right).
To determine whether the observed palmitoylation of the
mutant proteins is important for the maintenance of aggrega-
tion, cell lysates were treated with hydroxylamine to cleave
thioester linkages between cysteine residues and palmitate
chains. Hydroxylamine treatment dissolved the higher molec-
ular mass forms of L115R and L116 mutants co-expressed in
HEK293T cells with DHHC3 (Fig. 4B, left), confirming that
their SDS-resistant aggregation requires palmitoylation. This
same effect of hydroxylamine on mutant aggregates was also
observed when CSPs were expressed in PC12 cells without
DHHC co-expression (Fig. 4B, right).
Aggregation ofMutantCSPProteins in PostmortemSamples
from Patients with ANCL—The results presented thus far high-
light a possible role for palmitoylation-dependent aggregation
of mutant CSP in the development of ANCL. To explore fur-
ther the relevance of these findings to ANCL, brain lysates were
prepared from control individuals and DNAJC5 mutation car-
riers and incubated in the absence or presence of hydroxyla-
mine to test whether palmitoylation-sensitive aggregates were
present. Fig. 5 shows that high molecular mass SDS-resistant
aggregates were clearly detected in samples from ANCL
patients but not in control samples. Furthermore, immunore-
activity of these aggregates was greatly reduced following
hydroxylamine treatment.
Co-aggregation of Mutant and Wild-type CSP Proteins—
Because mutations in CSP cause autosomal dominant ANCL,
the L116 and L115R mutant proteins are toxic even in the
presence of a wild-type copy of the CSP gene. Therefore, it is
possible that the mutant proteins have the capacity to interfere
with the function of wild-type CSP.We examined this by test-
ing whether mutant CSP proteins induced co-aggregation of
wild-type CSP. For this, HEK293T cells were transfected with
myc-tagged wild-type CSP, DHHC3, and EGFP-tagged wild-
type or mutant CSP. Fig. 6 shows that in the presence of
EGFP-CSP L116 or L115Rmutants, a small fraction of myc-
CSPwas recruited into SDS-resistant aggregates. Thiswas not
observed following co-expression with either EGFP or EGFP-
CSPwild-type (Fig. 6). This result clearly highlights the poten-
tial of mutant CSP proteins to interfere with the wild-type
protein, offering a possible mechanism for the dominant effect
of these disease-causing mutants in the development of ANCL.
DISCUSSION
The link between proteinmisfolding/aggregation and neuro-
degeneration is well established for disorders such as
Alzheimer, Parkinson, and Huntington diseases (25). The
results presented in this study further highlight the correlation
betweenprotein aggregation andneurodegeneration,with respect
tomutantCSP andANCL. Perhaps themost intriguing observa-
tion in the present study is the link between aggregation of the
mutant CSP proteins and palmitoylation, highlighting the
interplay between genetic mutations and post-translational
modification in the induction of protein aggregation. Post-
FIGURE 3. Active DHHC palmitoyltransferases promote aggregation of CSP mutants. A, EGFP-CSP wild-type and L116/L115R mutants were co-
transfected into HEK293T cells with HA-DHHC3 (D3) or empty vector. Lysates were resolved by SDS-PAGE, transferred to nitrocellulose, and probed with
antibodies against GFP or HA. Nonpalmitoylated (np) and palmitoylated (p) CSP are marked by arrows, and aggregated (a) CSP is highlighted by a bracket.
Positions of molecular mass standards are shown on the left. B and C, HEK293T cells were transfected with EGFP-tagged constructs (B) or EGFP-tagged
constructs together with HA-DHHC3 (C). Co-transfected cells were fixed and stained with anti-HA, followed by an anti-mouse antibody conjugated to Alexa
Fluor 546. Cells were viewed using a Leica SP5 confocalmicroscope. Scale bars represent 5m, and the fluorescence intensity color code is shown.D, HEK293T
cells co-expressing the indicatedCSPproteins andDHHC3were fractionated into supernatant (S) andpellet (P) fractions, containing cytosolic andmembrane
proteins, respectively. The fractionationwas performed in the presence and absence of 1% Triton X-100 as indicated. Equal volumes of the recovered samples
were resolved by SDS-PAGE, transferred to nitrocellulose, and probed with antibodies against GFP, HA, and GAPDH. E, HEK293T cells co-expressing the CSP
proteins and DHHC3 were lysed in SDS-dissociation buffer containing 1, 5, or 25 mM DTT and were either heated to 100 °C (boil) or 37 °C (non-boil) for 5 min
before running. F, cells were transfected with EGFP-CSP and the indicated HA-DHHC proteins and analyzed as in A. The mean ratio of aggregated to
monomeric forms of each protein under the various transfection conditions was calculated and is presented together with S.E. (error bars) (n 3). Statistical
tests were performed using a one-way ANOVA, asterisks denote a p value of0.05 compared with proteins without DHHC co-expression.
FIGURE 4.Palmitoylation analysis of CSPmutants.A, HEK293T cells trans-
fected with the wild-type and mutant EGFP-CSP constructs and with () or
without () HA-DHHC3 (D3) were labeled with 0.5 mCi/ml [3H]palmitic acid
for 3 h. Cellswere lysed in SDS-dissociationbuffer, resolvedby SDS-PAGE, and
transferred tonitrocellulose.Duplicatenitrocellulosemembraneswere either
processed for detection of 3H signal (right) or probed by immunoblotting
with anti-GFP (left). B, HEK293T cells co-transfected with EGFP-CSP con-
structs and DHHC3 (left) or PC12 cells transfectedwith EGFP-CSP constructs
alone (right) were treated with hydroxylamine () or Tris () as described
under “Experimental Procedures.” The samples were then resolved by SDS-
PAGE and transferred to nitrocellulose for immunoblotting analysis using
antibodies against EGFP.Nonpalmitoylated (np) andpalmitoylated (p)mono-
meric CSP aremarked by arrows, and aggregated CSP (a) is highlighted by
a bracket. Positions of molecular mass standards are shown on the left.
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translational modifications such as phosphorylation and pro-
teolytic cleavage can modulate the aggregation of cytotoxic
mutant proteins in other neurodegenerative disorders (26), and
indeed blocking the palmitoylation of mutant Huntingtin
increased the formation of inclusions and enhanced toxicity
(27). The present study extends this link between neurodegen-
eration and palmitoylation and suggests that future success in
counteracting ANCL in patients carrying the disease-causing
CSP mutations might be achieved by targeting the palmitoy-
lation machinery.
It is intriguing that protein palmitoylation is implicated in
both infantile and adult-onset forms of NCL, albeit by different
mechanisms. A deficiency of the lysosomal thioesterase protein
palmitoyl thioesterase 1 causes early onset NCL (2), and this
enzyme is involved in depalmitoylation of proteins during their
degradation in lysosomes (29).We speculate that the palmitoy-
lated aggregates of CSPmutant proteinsmight be less suscep-
tible to the actions of lysosomal thioesterases, leading to a grad-
ual accumulation of palmitoylated CSP peptides. Thus, the
difference in age of symptomatic onset between the infantile
and adult-onset forms of ANCL may reflect a different rate of
accumulation of nondegraded palmitoylated peptides: rapid
accumulation due to a decreased cleavage of bulk palmitoylated
proteins following protein palmitoyl thioesterase 1 deficiency
(30) and a slower accumulation resulting from a decreased
sensitivity of a single protein (mutant CSP) to lysosomal
thioesterases.
What could be the underlying cause of the observed aggre-
gation of L115R andL116CSPmutants? First, it is important
to note that wild-type CSP has an intrinsic tendency to self-
associate (18), and indeed SDS-resistant dimers of wild-type
CSP are frequently observed in cellular samples (see Fig. 3E).
This self-association is dramatically enhanced by the L116
and L115R mutations, leading to the formation of high molec-
ular mass SDS-resistant aggregates that are not observed with
the wild-type protein. One possibility to explain these effects is
that the mutations promote a restructuring of the cysteine-
string domain resulting in added palmitate groups being posi-
tioned outside the hydrophobic core of the membrane bilayer.
Palmitate chains of different mutant CSP monomers might
then cluster together via lipid-lipid interactions to shield the
exposed palmitate chains from water. Indeed, it is possible that
the CSPmonomers within the aggregates are not fully palmi-
toylated. This is implied by the lower [3H]palmitate signal from
aggregates comparedwithmonomeric protein; for example, for
FIGURE 5. CSP expression and aggregation in human brain. Cortical
lysates fromcontrol andDNAJC5mutation carriers (three separate individuals
for each) were treated with hydroxylamine () or Tris (), resolved by SDS-
PAGE, and transferred to nitrocellulose for immunoblotting analysis using
antibodies against CSP, HSC70, and actin. Nonpalmitoylated (np) andpalmi-
toylated (p)monomeric CSP aremarkedbyarrows, and aggregatedCSP (a)
is highlighted by a bracket. Positions of molecular mass standards are shown
on the left.
FIGURE 6. Co-aggregation of wild-type and mutant CSP. HEK293T cells
were transfected with HA-DHHC3, myc-tagged CSP wild-type, and EGFP,
EGFP-CSP, EGFP-CSP (L116), or EGFP-CSP (L115R). Cell lysates were
resolved by SDS-PAGE and transferred to nitrocellulose for immunoblotting
analysis using antibodies against EGFP (left) and myc (right). Nonpalmitoy-
lated (np) and palmitoylated (p) monomeric CSP are marked by arrows, and
aggregated CSP (a) is highlighted by a bracket. Positions of molecular mass
standards are shown on the left.
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the data presented in Fig. 4A the 3H signal for the L116 and
L115R high molecular mass aggregates was 5.8- and 12.5-fold,
respectively, less than that from the corresponding monomers
when normalized to protein levels. This difference might sug-
gest that the aggregates contain partially palmitoylated mutant
monomers or amixture of palmitoylated and nonpalmitoylated
monomers. At present we remain cautious in our interpreta-
tion of the different 3H signals frommonomeric and aggregated
protein. In particular, it is not clear whether palmitate turnover
on themonomers and aggregates occurswith similar kinetics or
even whether the aggregation of mutant CSP somehow
reduces the 3H signal from associated palmitate chains. Dis-
rupting the mutant CSP aggregates into their constituent
monomers, without perturbing palmitoylation, would provide
a clearer indication of the palmitoylation status of individual
monomers within the aggregates; this is an area of investigation
that we are currently pursuing. Another possibility to explain
the palmitoylation-dependent aggregation is that the mutant
proteins are intrinsically more prone to self-associate (in their
nonpalmitoylated state). In this case, palmitoylation-induced
membrane binding might simply concentrate the mutant pro-
teins on cellular membranes facilitating aggregate formation in
a manner that does not directly involve palmitate chains.
Although this model is supported by the observation that bac-
terially expressed recombinant CSP self-associates via a
region containing the cysteine-string domain (18), this does not
readily fit with our data showing that the high molecular
mass mutant aggregates are disassembled by hydroxylamine
treatment.
Another point of note is that complete knock-out of CSP in
mice causes neurodegeneration (11). Thus, it is possible that
disease occurs in humans carrying the L115R/L116mutations
as a result of reduced levels of wild-type CSP. However, the
finding that CSP heterozygous knock-out mice have no overt
neurodegenerative phenotype might argue against this possi-
bility (11). Nevertheless, mutant forms of CSP could exhibit
a toxic gain-of-function effect through interfering with the
function or trafficking of wild-type CSP. Indeed, it was sug-
gested that there was a loss of immunofluorescence signal and
synaptic targeting of CSP in cerebral and cerebellar cortex
samples from a L115R mutation carrier (6). We detected the
recruitment of small amounts of myc-tagged wild-type CSP
protein into EGFP-tagged mutant aggregates (Fig. 6), and thus
aggregates containing both mutant and wild-type CSP in the
brains of ANCL patients are a possibility. Co-aggregation of
wild-type and mutant CSP may perturb synaptic targeting,
leading to destabilization of key synaptic proteins such as the
SNARE protein SNAP25 (31). The mutant aggregates might
also cause cellular toxicity by recruiting and sequestering other
key cellular proteins (28).
At present we are not certain why Nosková et al. (6) failed to
detect a major loss of palmitoylation of mutant EGFP-CSP
constructs in CAD5 cells. However, we note that the authors
did not confirm the identity of immunoreactive bands thatwere
proposed to represent palmitoylated and nonpalmitoylated
CSP (for example, by using hydroxylamine treatment). Full-
length immunoblots were also not presented in this study, pre-
venting an assessment of protein aggregation, althoughhydrox-
ylamine treatment of brain samples from an affected individual
that lacked CSP immunoreactivity led to the appearance of an
immunoreactive band that may represent a dimeric form of
CSP (6).
In summary, the results presented further highlight the rela-
tionship between protein aggregation and neurodegeneration,
while revealing a novel role for palmitoylation in driving aggre-
gation of disease-causing mutants.
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